A Case of Aplastic Anemia Associated With Long-Term Metronidazole Use.
Autor: Sam, Andrew M.; Saunders, Ila M.; Taplitz, Randy; Koura, Divya
Publication year: 2020
Journal of pharmacy practice
issn:1531-1937 0897-1900
doi: 10.1177/0897190019825584
Abstract:
Metronidazole is a nitroimidazole antibacterial agent that is highly effective for the treatment of protozoal and anaerobic infections. Metronidazole is known to cause hematologic adverse effects, including a reversible mild neutropenia; in rare circumstances, thrombocytopenia has been associated with metronidazole treatment. We present a case of aplastic anemia related to the extended use of metronidazole.
Language: eng
Rights:
Pmid: 30727812
Tags: Humans; Thrombocytopenia; Anti-Bacterial Agents/adverse effects; *Anemia, Aplastic/chemically induced/diagnosis; aplastic anemia; hematologic dyscrasia; metronidazole; Metronidazole/adverse effects; neutropenia
Link: https://pubmed.ncbi.nlm.nih.gov/30727812/